Cargando…

Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso

BACKGROUND: Investigating malaria transmission dynamics is essential to inform policy decision making. Whether multiplicity of infection (MOI) dynamic from individual infections could be a reliable malaria metric in high transmission settings with marked variation in seasons of malaria transmission...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sondo, Paul, Derra, Karim, Rouamba, Toussaint, Nakanabo Diallo, Seydou, Taconet, Paul, Kazienga, Adama, Ilboudo, Hamidou, Tahita, Marc Christian, Valéa, Innocent, Sorgho, Hermann, Lefèvre, Thierry, Tinto, Halidou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441709/ https://www.ncbi.nlm.nih.gov/pubmed/32819420 http://dx.doi.org/10.1186/s13071-020-04302-z

Ejemplares similares

Polymorphisme de Plasmodium falciparum et mutations des gènes de résistance Pfcrt et Pfmdr1 dans la zone de Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2021)

Plasmodium falciparum gametocyte carriage in symptomatic patients shows significant association with genetically diverse infections, anaemia, and asexual stage density
por: Sondo, Paul, et al.
Publicado: (2021)

Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2020)

Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2015)

Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2016)

Effectiveness and safety of artemether–lumefantrine versus artesunate–amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial
por: Sondo, Paul, et al.
Publicado: (2015)

Baseline malarial and nutritional profile of children under seasonal malaria chemoprevention coverage in the health district of Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2023)

Genetically diverse Plasmodium falciparum infections, within-host competition and symptomatic malaria in humans
por: Sondo, Paul, et al.
Publicado: (2019)

Socioeconomic and environmental factors associated with malaria hotspots in the Nanoro demographic surveillance area, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2019)

Assessment of a combined strategy of seasonal malaria chemoprevention and supplementation with vitamin A, zinc and Plumpy’Doz™ to prevent malaria and malnutrition in children under 5 years old in Burkina Faso: a randomized open-label trial (SMC-NUT)
por: Sondo, Paul, et al.
Publicado: (2021)

Population-based incidence, seasonality and serotype distribution of invasive salmonellosis among children in Nanoro, rural Burkina Faso
por: Guiraud, Issa, et al.
Publicado: (2017)

Impact and operational feasibility of adding malaria infection screening using an ultrasensitive RDT for placental and fetal outcomes in an area of high IPTP-SP coverage in Burkina Faso: the ASSER MALARIA pilot study protocol
por: Tahita, Marc Christian, et al.
Publicado: (2022)

Prospective observational study to evaluate the clinical and biological safety profile of pyronaridine–artesunate in a rural health district in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022)

Patterns of child mortality in rural area of Burkina Faso: evidence from the Nanoro health and demographic surveillance system (HDSS)
por: Noori, Navideh, et al.
Publicado: (2021)

Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial
por: Lingani, Moussa, et al.
Publicado: (2023)

Supporting evidence for a human reservoir of invasive non-Typhoidal Salmonella from household samples in Burkina Faso
por: Post, Annelies S., et al.
Publicado: (2019)

Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique
por: Tinto, Halidou, et al.
Publicado: (2015)

Malaria and curable sexually transmitted infections in pregnant women: A two-years observational study in rural Burkina Faso
por: Zango, Serge Henri, et al.
Publicado: (2020)

Enhanced effect of seasonal malaria chemoprevention when coupled with nutrients supplementation for preventing malaria in children under 5 years old in Burkina Faso: a randomized open label trial
por: Sondo, Paul, et al.
Publicado: (2023)

Malaria and curable sexually transmitted and reproductive tract coinfection among pregnant women in rural Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2021)

Gender differences in sociodemographic and behavioural factors associated with BMI in an adult population in rural Burkina Faso – an AWI-Gen sub-study
por: Boua, Romuald Palwende, et al.
Publicado: (2018)

Pathogens associated with acute diarrhea, and comorbidity with malaria among children under five years old in rural Burkina Faso
por: Lompo, Palpouguini, et al.
Publicado: (2021)

Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso
por: Tahita, Marc C, et al.
Publicado: (2015)

Safety Profile of Drug Use During Pregnancy at Peripheral Health Centres in Burkina Faso: A Prospective Observational Cohort Study
por: Rouamba, Toussaint, et al.
Publicado: (2018)

Boosting the impact of seasonal malaria chemoprevention (SMC) through simultaneous screening and treatment of household members of children receiving SMC in Burkina Faso: a protocol for a randomized open label trial
por: Sondo, Paul, et al.
Publicado: (2022)

High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2019)

In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2020)

Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022)

Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change
por: Tinto, Halidou, et al.
Publicado: (2014)

The impact of clinical research activities on communities in rural Africa: the development of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso
por: Tinto, Halidou, et al.
Publicado: (2014)

Asymptomatic malaria and anaemia among pregnant women during high and low malaria transmission seasons in Burkina Faso: household-based cross-sectional surveys in Burkina Faso, 2013 and 2017
por: Rouamba, Toussaint, et al.
Publicado: (2021)

Red blood cell homeostasis in children and adults with and without asymptomatic malaria infection in Burkina Faso
por: Kaboré, Berenger, et al.
Publicado: (2020)

Bayesian Spatiotemporal Modeling of Routinely Collected Data to Assess the Effect of Health Programs in Malaria Incidence During Pregnancy in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2020)

Treatable causes of fever among children under five years in a seasonal malaria transmission area in Burkina Faso
por: Kiemde, Francois, et al.
Publicado: (2018)

Undernutrition in children aged 0–59 months by region and over time: secondary analysis of the Burkina Faso 2012–2018 National Nutrition Surveys
por: Boua, Palwende Romuald, et al.
Publicado: (2023)

Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
por: Rouamba, Toussaint, et al.
Publicado: (2021)

Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018
por: Gansané, Adama, et al.
Publicado: (2021)

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
por: Datoo, Mehreen S, et al.
Publicado: (2021)

An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso
por: Valea, Innocent, et al.
Publicado: (2012)

Age-modified factors associated with placental malaria in rural Burkina Faso
por: Bihoun, Biébo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kar60oevmtbed4vbnk8hn7jl35